| Recruiting | Study of High-Precision Evaluation of Molecular ResiduaL Disease Through a PlatfOrm for Cancer TracKing and In NCT07524114 | University Health Network, Toronto | — |
| Not Yet Recruiting | Food-related Quality of Life in Patients With Cancer NCT07437326 | Hospices Civils de Lyon | — |
| Not Yet Recruiting | DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Y NCT07440290 | Cancer Research UK | Phase 2 / Phase 3 |
| Recruiting | Safety, Tolerance and Preliminary Efficacy of XH001 Injection Combined With Neoantigen Vaccine-induced Tumor-s NCT07329894 | Beijing GoBroad Hospital | Phase 1 |
| Not Yet Recruiting | A Study of DB-1324 in Advanced/Metastatic Gastrointestinal Tumors NCT07263594 | DualityBio Inc. | Phase 1 / Phase 2 |
| Recruiting | Intraoperative Imaging of Gastrointestinal Malignancies Using Pafolacianine (CYTALUX™) NCT07124351 | Cedars-Sinai Medical Center | Phase 4 |
| Not Yet Recruiting | Hyperthermia Combined With Immune Checkpoint Inhibitors in the Treatment of Advanced Gastrointestinal Malignan NCT07118566 | China Medical University, China | Phase 2 |
| Recruiting | Evaluating Microarray Pharmacogenetic Testing in Cancer Patients NCT06489041 | Wake Forest University Health Sciences | N/A |
| Enrolling By Invitation | Postbiotics for Mitigation of Postoperative Dysbiosis in Gastrointestinal Cancer Surgery NCT07050485 | University of South Florida | N/A |
| Recruiting | Sarcopenia and Neuromuscular Block in Gastrointestinal Cancer Surgery NCT07003061 | Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital | — |
| Withdrawn | Dyadic Text-Messaging Micro-Intervention NCT05917990 | Duke University | N/A |
| Recruiting | BOLSTER: Learning New Skills to Thrive NCT06936878 | Dana-Farber Cancer Institute | N/A |
| Active Not Recruiting | A Study of Raludotatug Deruxtecan (R-DXd) in People With Gastrointestinal Cancers (MK-5909-005) NCT06864169 | Merck Sharp & Dohme LLC | Phase 2 |
| Recruiting | Total Neoadjuvant FLOT Chemotherapy in Locally Advanced Gastric and Gastroesophageal Junction Cancer NCT06028737 | Ukrainian Society of Clinical Oncology | Phase 2 / Phase 3 |
| Recruiting | Evaluation of the Preliminary Efficacy and Safety of DR30206 in Combination With Standard Therapy in Patients NCT07056777 | Zhejiang Doer Biologics Co., Ltd. | Phase 1 / Phase 2 |
| Recruiting | Fatigue and Molecular Mechanisms in Cancer Patients Receiving CCRT NCT06633224 | University of California, San Francisco | — |
| Recruiting | Palliative Radiotherapy in Symptomatic Pelvic Soft Tissue Tumors NCT06398314 | Sykehuset Telemark | N/A |
| Recruiting | EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With NCT06263088 | Case Comprehensive Cancer Center | N/A |
| Recruiting | Sacituzumab Govitecan in Combination With Capecitabine for Advanced Gastrointestinal Cancers After Progression NCT06065371 | Henry Ford Health System | Phase 1 |
| Recruiting | PhI Pilot Study Pafolacianine Inject for Intraoperative Imaging on Outcomes of GI Cancer Peritoneal Carcinomat NCT06511037 | University of California, Irvine | EARLY_Phase 1 |
| Recruiting | Study of Patritumab Deruxtecan in Participants With Gastrointestinal Cancers (MK-1022-011) (HERTHENA-PanTumor0 NCT06596694 | Merck Sharp & Dohme LLC | Phase 1 / Phase 2 |
| Recruiting | Dyadic Sleep Study NCT06569693 | University of Miami | N/A |
| Completed | Nudge Strategies for DPYD Testing in Patients With Gastrointestinal Cancers Treated With Fluoropyrimidines NCT06559462 | Abramson Cancer Center at Penn Medicine | N/A |
| Recruiting | Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma NCT06582017 | Nammi Therapeutics Inc | Phase 1 |
| Active Not Recruiting | Effect of Silkworm Pupa Tablets in Gastrointestinal Malignancies at Nutritional Risk Following Radical Surgery NCT06551675 | Xiaosun Liu, MD | N/A |
| Recruiting | REmote Symptom COllection to improVE postopeRative Care NCT06190730 | Medstar Health Research Institute | N/A |
| Recruiting | A Study of GC203 TIL in Advanced Malignant Solid Tumors NCT06375187 | Shanghai Juncell Therapeutics | Phase 1 |
| Recruiting | Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors NCT06445062 | Revolution Medicines, Inc. | Phase 1 / Phase 2 |
| Active Not Recruiting | Autologous T-cells Genetically Engineered to Express Receptors Reactive Against KRAS Mutations in Conjunction NCT06253520 | National Cancer Institute (NCI) | Phase 1 |
| Recruiting | Goals of Care Discussion for Patients With Advanced Lung and Gastrointestinal Cancer in the Emergency Departme NCT06420206 | M.D. Anderson Cancer Center | N/A |
| Recruiting | EUS Examination Using EndoSound Vision System vs. Standard Echoendoscope NCT06340620 | Orlando Health, Inc. | N/A |
| Active Not Recruiting | A Study to Test Different Doses of BI 765049 Alone and in Combination With Ezabenlimab in Asian People With Ad NCT06091930 | Boehringer Ingelheim | Phase 1 |
| Recruiting | Comparison of Outcomes of Multiple Platforms for Assisted Robotic - Gastrectomy NCT06362070 | Azienda Ospedaliera Universitaria Integrata Verona | N/A |
| Completed | Mind Over Matter for Black and African American Women: A Single Arm Trial Examining Feasibility and Acceptabil NCT06168825 | Inova Health Care Services | — |
| Recruiting | SGM-101 in Colorectal Brain Metastases. NCT04755920 | Leiden University Medical Center | Phase 2 |
| Recruiting | Probiotics for Depression in Cancer Patients NCT06496438 | Aristotle University Of Thessaloniki | N/A |
| Active Not Recruiting | Avatrombopag vs. Placebo for CIT in GI Malignancies NCT05772546 | Hanny Al-Samkari, MD | Phase 2 |
| Recruiting | Bioelectrical Impedance Analysis for Perioperative Fluid Evaluation in Colorectal Cancer Surgery NCT07404527 | Institute of Oncology Ljubljana | N/A |
| Recruiting | BGT007 Cells for the Treatment of Refractory Digestive System Tumors NCT06104241 | The Affiliated Hospital of Xuzhou Medical University | EARLY_Phase 1 |
| Terminated | Ketamine-assisted Psychotherapy (KAP) for Patients With Existential Distress Associated With Non-operable GI C NCT06001372 | University of Utah | EARLY_Phase 1 |
| Recruiting | JUMP_START - Optimization of Care for Young Cancer Patients with Gastrointestinal Tumors NCT06621277 | University Hospital Heidelberg | — |
| Recruiting | Sarcopenia Risk Screening in Patients With Gastrointestinal Cancer Using SARC-F NCT07405307 | Institute of Oncology Ljubljana | — |
| Recruiting | A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue NCT05837767 | Memorial Sloan Kettering Cancer Center | N/A |
| Completed | ONS in Gastrointestinal Cancer Patients Undergoing Chemotherapy NCT05980624 | Beni-Suef University | Phase 2 |
| Unknown | Adapting the Tumor Board Model for Mental Illness and Cancer NCT05837598 | Massachusetts General Hospital | N/A |
| Unknown | 68Ga-PMD22 PET/CT Examination Targeting CLDN18.2 NCT05937919 | Peking Union Medical College Hospital | EARLY_Phase 1 |
| Active Not Recruiting | ChatBot and Activity Monitoring in Patients Undergoing Chemoradiotherapy NCT05318027 | Abramson Cancer Center at Penn Medicine | Phase 2 |
| Enrolling By Invitation | Prospective Procurement of Tumor Tissue to Identify Novel Therapeutic Targets and Study the Tumor Microenviron NCT05600933 | National Cancer Institute (NCI) | — |
| Unknown | Study of 18F-FAPI Applied to Gastrointestinal Cancer NCT05788874 | First Affiliated Hospital Xi'an Jiaotong University | — |
| Recruiting | A Study on the Effects of Exercise on Side Effects From Treatment for Gastrointestinal Cancers NCT05789485 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Active Not Recruiting | Palliadelic Treatment to Reduce Psychological Distress in Persons With Advanced Gastrointestinal Cancers NCT05220046 | University of Nebraska | Phase 1 |
| Recruiting | SURGE: Supporting UnderRepresented Minorities in Genomics-based Cancer Trial Enrollment (Intervention) NCT05375643 | Nadine McCleary, MD, MPH | N/A |
| Recruiting | Disease Outcomes and Toxicities in Patients With Gastrointestinal and Sarcomatous Malignancies NCT05743426 | UNC Lineberger Comprehensive Cancer Center | — |
| Completed | Endoscopic Nebulizing Device for Surgical Haemostatic-sealant Glubran® 2 Usability Trial in EMR and ESD NCT06588881 | GEM SRL | N/A |
| Active Not Recruiting | Frailty in Patients With Gastrointestinal Cancer Who Are Undergoing Major Surgery NCT05694338 | The Guthrie Clinic | — |
| Recruiting | Quality of Care in Relationship to Aborted Cancer Surgery NCT05808712 | Linkoeping University | — |
| Recruiting | Remote Resistance Exercise Powering Survivors - Gastrointestinal Oncology NCT05664178 | H. Lee Moffitt Cancer Center and Research Institute | Phase 1 / Phase 2 |
| Recruiting | Optimizing and Personalising Azacitidine Combination Therapy for Treating Solid Tumours QPOP and CURATE.AI NCT05381038 | National University Hospital, Singapore | Phase 1 / Phase 2 |
| Completed | The Science of the Art of Palliative Care NCT05137782 | Dartmouth-Hitchcock Medical Center | N/A |
| Unknown | GastroIntestinal Cancer in Children and Adolescents NCT05693519 | Paul G. Kemps, MD | — |
| Completed | Artificial Intelligence and Cancer Staging in Upper Gastrointestinal Malignancies NCT05648084 | Sebahattin Celik MD | — |
| Recruiting | Pemigatinib in the Advanced Gastrointestinal Cancer With FGFR 1-3 Alterations NCT05651672 | Tianjin Medical University Cancer Institute and Hospital | Phase 2 |
| Completed | STRONG Program for Cancer Patients NCT05649969 | H. Lee Moffitt Cancer Center and Research Institute | N/A |
| Recruiting | To Test the Food for Special Medical Purpose in Perioperative Patients With Gastrointestinal Cancer NCT05606848 | Fresenius Kabi Sino-Swed Pharmaceutical Corp. Ltd | N/A |
| Active Not Recruiting | Pathways to Advance Targeted and Helpful Serious Illness Conversations (PATH-SIC) NCT05629065 | Dana-Farber Cancer Institute | N/A |
| Active Not Recruiting | Real World Treatment Experience of Patients With Breast, Lung, or GI Cancer or Multiple Myeloma Using Remote S NCT05587972 | Carevive Systems, Inc. | N/A |
| Recruiting | PSMA in Gastroenterologic Tumors (GIPSMA) NCT05547919 | Wuerzburg University Hospital | N/A |
| Unknown | Immunological Variables Associated to ICI Toxicity in Cancer Patients NCT05429866 | Jules Bordet Institute | Phase 2 |
| Unknown | A Single-Arm Phase II Exploratory Clinical Study of Pemigatinib in the Treatment of Advanced Gastrointestinal NCT05559775 | Zhejiang Cancer Hospital | Phase 2 |
| Completed | The BurnAlong Pilot Study for Adolescent and Young Adult Cancer Survivors NCT05131815 | Cedars-Sinai Medical Center | N/A |
| Completed | Clinical Translation of a Novel FAPI Dimer [68Ga]Ga-LNC1013 NCT06159049 | Xiangya Hospital of Central South University | — |
| Terminated | Microbiome in Colorectal Cancer Onset and Progression NCT05368688 | Viome | — |
| Completed | Food for Special Medical Purpose in Patients With Digestive Tract Tumor NCT05301556 | Abbott Nutrition | N/A |
| Recruiting | Neratinib and Fam-Trastuzumab Deruxtecan in Advanced Gastro-esophageal Cancer Patients NCT05274048 | Fox Chase Cancer Center | Phase 1 |
| Unknown | Fibroblast Activation Protein Inhibitor PET/CT Imaging in Malignant Tumor of Digestive System NCT05420558 | Zhongnan Hospital | — |
| Completed | Treatment of Cabotamig (ARB202) in Advanced Gastrointestinal Cancer Patients NCT05411133 | Arbele Pty Ltd | Phase 1 |
| Terminated | Trial of Ulixertinib in Combination With Hydroxychloroquine in Patients With Advanced Gastrointestinal (GI) Ma NCT05221320 | BioMed Valley Discoveries, Inc | Phase 2 |
| Unknown | Use of DRS Probe and Tracking for In-vivo Application NCT05830292 | Imperial College London | N/A |
| Recruiting | Improving Comprehensive Care of Cancer Patients NCT05323409 | Baylor College of Medicine | N/A |
| Completed | Intestinal Microbiome, Oral Microbiome, and Whole Blood Transcriptome Analyses in Gastrointestinal Malignancie NCT05462314 | Viome | — |
| Completed | Nutritional and Functional Assessment of Patients Undergoing Surgery Due to Gastrointestinal Cancer (NUFAGI). NCT05795374 | Maximos Frountzas | — |
| Recruiting | The PhOCus Trial: Implementation of Pharmacogenomic Testing in Oncology Care NCT04541381 | University of Chicago | N/A |
| Active Not Recruiting | Analyzing Clinical Outcomes and Genomic Data of American Indian Patient Population NCT05863052 | University of Oklahoma | — |
| Recruiting | Resilience and Equity in Aging, Cancer, and Health (REACH) NCT04674267 | Dana-Farber Cancer Institute | N/A |
| Withdrawn | Acupuncture for the Treatment of Postoperative Ileus After Gastrointestinal Surgery NCT04713241 | Case Comprehensive Cancer Center | N/A |
| Suspended | Patient Reported Scale vs CTCAE Grading: A Prospective Comparator Study NCT05158907 | Tata Medical Center | N/A |
| Unknown | Management of Oxaliplatin-related Gastroesophageal Variceal Bleeding NCT05141617 | Shanghai Zhongshan Hospital | N/A |
| Completed | A Clinical Study of TJ004309 With Atezolizumab (TECENTRIQ®) in Patients With Ovarian Cancer and Selected Solid NCT05001347 | I-Mab Biopharma US Limited | Phase 2 |
| Unknown | ALDH Enzyme in CRF With Advanced GI Cancer NCT05030363 | Korea University Anam Hospital | N/A |
| Recruiting | Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosi NCT04847063 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Preoperative Prognostic Nutritional Index and Postoperative Delirium in Gastrointestinal Cancer Surgery NCT06603129 | Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital | — |
| Active Not Recruiting | Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases NCT04899908 | Brigham and Women's Hospital | Phase 2 |
| Active Not Recruiting | Advancing Nursing Practices in Hospital Oncology Care NCT05053191 | Memorial Sloan Kettering Cancer Center | N/A |
| Unknown | Gastrointestinal Emergency Surgery: Evaluation of Morbidity and Mortality NCT05226221 | Campus Bio-Medico University | — |
| Unknown | the Effect of ABCC2 Genetic Polymorphism on Neurotoxicity in Gastrointestinal Cancer Patients Receiving Oxalip NCT05494320 | Ain Shams University | — |
| Completed | 'Penny', a SMS Text-based Chatbot Intervention for Medication Adherence and Side Effect Management Among Patie NCT05113264 | Abramson Cancer Center at Penn Medicine | N/A |
| Completed | Nutritional Risk Screening Nutritional Support Gastrointestinal Cancer NCT06018246 | The First Affiliated Hospital of Shanxi Medical University | N/A |
| Recruiting | Electroporation for Cancer Treatment Real World Registry NCT04929912 | Mirai Medical | — |
| Withdrawn | Relationship Between Circulating Tumor Cell Cultures' Treatment Response and Clinical Outcomes NCT04280640 | UNC Lineberger Comprehensive Cancer Center | — |
| Completed | Assessments of Genetic Counseling Augmented With an Educational Video or Pamphlet Versus Traditional Counselin NCT05132868 | Stanford University | N/A |
| Completed | Routine Evaluation of the Social Determinants of Health in Oncology: User-centered Resource Coordination and E NCT04879927 | Dana-Farber Cancer Institute | N/A |
| Unknown | CLDN18.2 Targeting PET Imaging in Patients With Gastrointestinal Tumors NCT04883970 | Peking University Cancer Hospital & Institute | N/A |
| Completed | Implementing Pharmacogenetic Testing in Gastrointestinal Cancers NCT04736472 | Abramson Cancer Center at Penn Medicine | N/A |
| Unknown | Therapeutic Endoscopic Ultrasound for Gastrointestinal Disorders: A Multicenter Registry Study NCT05051358 | Advanced Endoscopy Research, Robert Wood Johnson Medical School Rutgers University | — |
| Completed | Seal-G / Seal-G MIST Study NCT04532515 | Advanced Medical Solutions Ltd. | N/A |
| Recruiting | EUS Guided HVA and PVA for Circulating Tumor DNA in Patients NCT04782557 | Chinese University of Hong Kong | N/A |
| Withdrawn | A Safety Study of TMV-018 in Patients With Tumors of the Gastrointestinal Tract NCT04195373 | Themis Bioscience GmbH | Phase 1 |
| Completed | Improving Cancer On-treatment Symptom Management NCT04589247 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | — |
| Completed | Impact Of Nurse Navigation Program on Outcomes in Patients With GI Cancers NCT04602611 | Wake Forest University Health Sciences | N/A |
| Unknown | The Rome Trial From Histology to Target: the Road to Personalize Target Therapy and Immunotherapy NCT04591431 | Fondazione per la Medicina Personalizzata | Phase 2 |
| Withdrawn | Remote Electronic Patient Monitoring in Gastrointestinal Cancer NCT04030624 | Massachusetts General Hospital | N/A |
| Completed | Investigation of Immune Modulation by Modern Acupuncture in Gastroenterologic Cancers NCT04692454 | Taipei Medical University WanFang Hospital | N/A |
| Completed | The Status of Immune Checkpoints at Gastrointestinal Cancer NCT04566848 | Istanbul Training and Research Hospital | — |
| Recruiting | Investigating the Effects of Atezolizumab in People Whose Tumour DNA or RNA Indicates Possible Sensitivity NCT04273061 | British Columbia Cancer Agency | Phase 2 |
| Completed | A Study of Metastatic Gastrointestinal Cancers Treated With Tumor Infiltrating Lymphocytes in Which the Gene E NCT04426669 | Intima Bioscience, Inc. | Phase 1 / Phase 2 |
| Unknown | A Multicenter Prospective Post-registration Study of Empegfilgrastim to Evaluate Safety and Efficacy in Specia NCT04905329 | Moscow Clinical Scientific Center | — |
| Completed | Evaluating the Combined Intervention of Nutritional Supplementation (Remune) and Exercise in Patients With Can NCT04131426 | University of Rochester | Phase 1 |
| Withdrawn | Sleep Disturbances in Surgical Patients With GI Cancers: A Quantitative and Qualitative Analysis NCT05044312 | M.D. Anderson Cancer Center | N/A |
| Terminated | Study of Combination Therapy With the MEK Inhibitor, Cobimetinib, Immune Checkpoint Blockade, Atezolizumab, an NCT04214418 | Columbia University | Phase 1 / Phase 2 |
| Unknown | Q-GAIN (Using Qpop to Predict Treatment for GAstroIntestinal caNcer) NCT04611035 | National University Hospital, Singapore | — |
| Unknown | Microbiome Analysis in esoPhageal, PancreatIc and Colorectal CaNcer Patients Undergoing Gastrointestinal Surge NCT04189393 | Radboud University Medical Center | — |
| Active Not Recruiting | ctDNA-guided Surveillance for Stage III CRC, a Randomized Intervention Trial NCT04084249 | Claus Lindbjerg Andersen | N/A |
| Completed | Study on the Efficacy and Safety of Enhanced Recovery After Surgery （ERAS）in Gastrointestinal Cancer NCT04201730 | Huashan Hospital | N/A |
| Unknown | The Clinical Study of Modern Therapies on Flora in Body Fluids and Blood of Malignant Tumor Patients NCT04202848 | The First Affiliated Hospital of Dalian Medical University | — |
| Completed | Ultrasound for the Detection of Oxaliplatin-Induced Peripheral Neuropathy NCT03958747 | Wake Forest University Health Sciences | N/A |
| Terminated | Assessment of a Serious Illness Conversation Guide (SICG) in Advanced Gastro-Intestinal Cancers NCT04077372 | Stanford University | N/A |
| Completed | Effectiveness of Low Dose Aspirin in Decreasing the Chance Getting Stomach and Intestine Cancer NCT04081831 | Bayer | — |
| Completed | Symptom Management Implementation of Patient Reported Outcomes in Oncology NCT03850912 | Dana-Farber Cancer Institute | N/A |
| Completed | Microvascular Function in Patients Undergoing 5-Fluorouracil Chemotherapy NCT04042298 | Kansas State University | — |
| Recruiting | Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors NCT04354064 | Washington University School of Medicine | — |
| Completed | Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12D Varia NCT03745326 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Recruiting | OH2 Oncolytic Viral Therapy in Solid Tumors NCT03866525 | Binhui Biopharmaceutical Co., Ltd. | Phase 1 / Phase 2 |
| Completed | EHR-embedded OCDT in Breast or GI Cancer NCT03858712 | Dana-Farber Cancer Institute | N/A |
| Unknown | Sensitivity and Specificity of NGS in Detecting bMSI in Patients With Gastric, Duodenal and Small Intestinal C NCT03915171 | China Medical University, China | N/A |
| Completed | Inhaled Essential Oil Effect on Common QOL Concerns During Cancer Treatment NCT03858855 | Ohio State University Comprehensive Cancer Center | N/A |
| Unknown | Prediction of Abdominal Complications After GastroEnterological Surgery NCT03828266 | Peking University | — |
| Unknown | Prediction of Intra-abdominal Infectious Complication by Drainage Fluid Analysis NCT03862378 | Peking University | — |
| Unknown | An Exploratory Trail of Camrelizumab Plus Apatinib Mesylate for Advanced Gastrointestinal NCT05225844 | Harbin Medical University | Phase 2 |
| Unknown | Multi-modality Imaging in Peritoneal Carcinomatosis of Colorectal Origin NCT03699332 | Radboud University Medical Center | Phase 1 / Phase 2 |
| Completed | Intraoperative TAP Block With Bupivacaine/Dexamethasone Against Liposomal Bupivacaine (Exparel®) NCT03723447 | Cedars-Sinai Medical Center | Phase 4 |
| Completed | Effects of Immunonutrition (Impact Oral®) in Patients Undergoing Surgery for Gastrointestinal Cancer NCT03665714 | Société des Produits Nestlé (SPN) | N/A |
| Completed | PeRioperative Optimization With Nutritional Supplements for Patients Undergoing GastRointEStinal Surgery for C NCT03445260 | Hamilton Health Sciences Corporation | N/A |
| Completed | Perioperative Palliative Care Surrounding Cancer Surgery for Patients & Their Family Members NCT03611309 | Stanford University | N/A |
| Unknown | Indocyanine Green Fluorescence Imaging in Prevention of Colorectal Anastomotic Leakage NCT03602677 | Oulu University Hospital | N/A |
| Unknown | Nutrition-support-team Based Intervention in Patients With Advanced Gastrointestinal Cancer NCT03631537 | First Affiliated Hospital Xi'an Jiaotong University | N/A |
| Unknown | Prehabilitation to Improve Cancer Surgery Outcomes NCT03502317 | Mount Sinai Hospital, Canada | N/A |
| Completed | Study of D07001-Softgel Capsules in Subjects With Gastrointestinal Cancer in Dose-Escalation Phase and in Subj NCT03531320 | InnoPharmax Inc. | Phase 1 / Phase 2 |
| Unknown | Next-generation Sequencing in Gastrointestinal Cancer NCT03476057 | Fujian Cancer Hospital | — |
| Terminated | Postoperative Chemoradiation or Chemotherapy After Preoperative Chemotherapy for Gastric Cancers NCT03515941 | Tannaz Armaghany | EARLY_Phase 1 |
| Completed | Adherence to Exercise and Dietary Intervention in Cancer Patients NCT05237921 | Hospital Beatriz Ângelo | N/A |
| Completed | Exercise to Reduce Chemotherapy-Induced Peripheral Neuropathy NCT03515356 | University of Michigan Rogel Cancer Center | N/A |
| Completed | A Study of RGX-202-01 (Ompenaclid) as Combination Therapy in RAS Mutant Advanced Colorectal Cancer NCT03597581 | Inspirna, Inc. | Phase 1 |
| Terminated | Messenger RNA (mRNA)-Based, Personalized Cancer Vaccine Against Neoantigens Expressed by the Autologous Cancer NCT03480152 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Unknown | Clinical Research on Teratment of Gastrointestinal Cancer in the Preoperative by Propranolol NCT03245554 | Central South University | EARLY_Phase 1 |
| Completed | BOLSTER: Building Out Lifelines for Safety, Trust, Empowerment and Renewal NCT03367247 | Dana-Farber Cancer Institute | N/A |
| Terminated | Ability of a Dendritic Cell Vaccine to Immunize Melanoma or Epithelial Cancer Patients Against Defined Mutated NCT03300843 | National Cancer Institute (NCI) | Phase 2 |
| Unknown | Safety and Efficacy of an Anticancer Medication Combined With Immune Cells in Subjects With Gastrointestinal C NCT03474861 | Hangzhou Converd Co., Ltd. | Phase 1 |
| Completed | Yoga for Psychological Distress in Gynecologic, Gastrointestinal, or Thoracic Cancer NCT03385577 | University of Florida | N/A |
| Completed | Bridge: Proactive Psychiatry Consultation and Case Management for Patients With Cancer NCT03360695 | Massachusetts General Hospital | N/A |
| Completed | A Study of Bemarituzumab (FPA144) Combined With Modified FOLFOX6 in Gastric/Gastroesophageal Cancer NCT03343301 | Five Prime Therapeutics, Inc. | Phase 1 |
| Recruiting | Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Varia NCT03190941 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Unknown | Analysis of Nutrition During Chemoradiotherapy in Patients With Gastrointestinal Cancer NCT03286348 | Fudan University | — |
| Completed | A Phase II Trial of Ipilimumab and Nivolumab for the Treatment of Rare Cancers NCT02923934 | Olivia Newton-John Cancer Research Institute | Phase 2 |
| Terminated | Correlation Between Intraocular Pressure Measurement by Tomometer and Anterior Chamber Depth Measurement by Ul NCT02818530 | Tata Memorial Centre | N/A |
| Unknown | Phase 1 Dose Escalation Study of CGX1321 in Subjects With Advanced Gastrointestinal Tumors NCT03507998 | Curegenix Inc. | Phase 1 |
| Completed | A Simple Walking Program to Enhance Concurrent Chemoradiotherapy Delivery NCT03115398 | Montefiore Medical Center | N/A |
| Completed | Effectiveness of Lay Navigators in Meeting Cancer Patients' Non-Clinical Needs: A Pilot Study NCT03245788 | Stanford University | N/A |
| Unknown | Registry of Huaier Granule for Prevention of Recurrence and Metastasis of Gastrointestinal Cancer After Radica NCT02975661 | Qidong Gaitianli Medicines Co., Ltd | — |
| Completed | Improving Evidence-Based Care for Cancer Patients NCT03207594 | Medical University of South Carolina | — |
| Recruiting | Immunobiology Blood and Tissue Collection of Upper Aerodigestive Malignancies NCT05995821 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | — |
| Recruiting | Ontario-wide Cancer TArgeted Nucleic Acid Evaluation NCT02906943 | University Health Network, Toronto | — |
| Completed | The Effects of a 12 Week Home-based Exercise Intervention on Physical Performance in Patients With Cancers of NCT04802486 | University of Rochester | N/A |
| Completed | Beyond Performance Status: Electronic Activity Monitoring to Assess Functional Activity of Patients With Gastr NCT02909062 | Memorial Sloan Kettering Cancer Center | — |
| Completed | A Study to Evaluate the Safety and Tolerability of Using SHR-1210 by Advanced Solid Tumor Subjects NCT02742935 | Jiangsu HengRui Medicine Co., Ltd. | Phase 1 |
| Unknown | COMplementary Hand-foot Massage to Improve Experience of illneSs Trial NCT02741401 | Zuyderland Medisch Centrum | N/A |
| Completed | Skeletal Muscle Energy Metabolism in Undernourished Patients With Gastrointestinal Cancer NCT02573974 | University Hospital, Tours | N/A |
| Active Not Recruiting | Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive Cancer NCT02293954 | City of Hope Medical Center | N/A |
| Completed | Prospective Observational Study Comparing Calcium and Sodium Levofolinate in Combination With 5-Fluorouracil ( NCT04680104 | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | — |
| Unknown | Capecitabine in Metastatic Breast and GI Cancers NCT02595320 | Qamar Khan | Phase 2 |
| Completed | Feasibility of Activity Monitoring in Patients With Cancer: Physical Activity Monitoring in Cancer Patients (P NCT02583815 | University of Texas Southwestern Medical Center | — |
| Completed | NextSteps Intervention for Advanced Cancer Patients and Caregivers NCT04885439 | Baylor College of Medicine | N/A |
| Completed | Standard Care Alone or With Acupuncture for CIPN in Breast Cancer and Multiple Myeloma NCT02275403 | The Christie NHS Foundation Trust | Phase 2 |
| Terminated | AZD9150, a STAT3 Antisense Oligonucleotide, in People With Malignant Ascites NCT02417753 | National Cancer Institute (NCI) | Phase 2 |
| Withdrawn | C-Met Inhibitor AMG 337, Oxaliplatin, Leucovorin Calcium, and Fluorouracil in Treating Patients With Advanced NCT02344810 | Eastern Cooperative Oncology Group | Phase 1 / Phase 2 |
| Unknown | Fish Oil Supplementation in Gastrointestinal Cancer NCT02699047 | Universidade Federal de Santa Catarina | N/A |
| Completed | A Feasibility Trial of Geriatric Assessment and Management for Older Cancer Patients NCT02222259 | University of Toronto | N/A |
| Completed | The Laparotomy Study NCT02140593 | Herlev Hospital | Phase 4 |
| Completed | Impact of Geriatrician Interventions on Chemotherapy Delivery in Vulnerable Elderly Oncology Patients NCT02785887 | Azienda USL 4 Prato | N/A |
| Completed | Efficacy of Radiotherapy in Combination With Zoledronic Acid in Bone Metastasis Patients With Gastrointestinal NCT02784652 | Severance Hospital | Phase 2 |
| Completed | Laparoscopic Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) for Metastatic Gastric Cancer NCT02092298 | M.D. Anderson Cancer Center | Phase 2 |
| Terminated | Study of Parenteral Nutrition to Patients With Gastrointestinal Cancer NCT02066363 | Odense University Hospital | N/A |
| Completed | Study to Compare Cardiovascular Side Effects of Teysuno Versus Capecitabine NCT01845337 | University of Edinburgh | Phase 2 |
| Unknown | Effect of COX-2 Selective Inhibitors on Postoperative Insulin Resistance After Gastrointestinal Laparoscopic S NCT01930318 | Jinling Hospital, China | Phase 4 |
| Completed | Electronic Patient Reported Symptom Assessment NCT01833637 | Northwestern University | N/A |
| Unknown | Infrastructure for Developing Gastrointestinal Cancer Prognostic and Predictive Markers NCT00716209 | Haematology-Oncology | — |
| Completed | Collecting Solid Tumor Tissue to Identify New Treatments NCT01658917 | National Cancer Institute (NCI) | — |
| Completed | Immunonutrition and Quality of Life of Cancer Patients Undergoing Oncological Treatment NCT01423799 | Société des Produits Nestlé (SPN) | Phase 3 |
| Completed | Fosaprepitant Dimeglumine in Preventing Nausea and Vomiting in Patients With Gastrointestinal Cancer Receiving NCT01504711 | Philip Philip | N/A |
| Unknown | Study of DPD for Predicting Efficacy and Safety to S-1 Plus Oxaliplatin in Gastrointestinal Cancer NCT01608646 | Xijing Hospital | Phase 2 |
| Completed | Nutrition and Physical Exercise Study NCT01540968 | Kantonsspital Winterthur KSW | N/A |
| Completed | Rocking Motion: Physiologic Effect on the Surgical Stress Response NCT01200316 | M.D. Anderson Cancer Center | Phase 1 |
| Completed | Patient Factors Impacting Adherence to Oral Chemotherapy NCT01487343 | Memorial Sloan Kettering Cancer Center | — |
| Unknown | Biomarker Analysis of Gastrointestinal Cancer NCT01484444 | Samsung Medical Center | — |
| Completed | Doxorubicin With or Without Sildenafil, With Analysis of Cardiac Markers NCT01375699 | Virginia Commonwealth University | Phase 1 |
| Completed | Proton Radiotherapy for Upper Gastrointestinal Malignancies NCT01449864 | Abramson Cancer Center at Penn Medicine | N/A |
| Completed | Pilot Study of Strength and Balance Training Program for Persons With Oxaliplatin Induced Neuropathy NCT01422993 | H. Lee Moffitt Cancer Center and Research Institute | N/A |
| Terminated | HYPAZ: Hypertension Induced by Pazopanib NCT01392352 | Cambridge University Hospitals NHS Foundation Trust | Phase 2 |
| Recruiting | Acquisition of Blood and Tumor Tissue Samples From Patients With Gastrointestinal Cancer NCT01313442 | National Cancer Institute (NCI) | — |
| Withdrawn | Tasigna Neoadjuvant Gastrointestinal Stromal Tumor (GIST) NCT01270893 | M.D. Anderson Cancer Center | Phase 2 |
| Completed | CAPOX in KRAS Wild-Type Advanced Adenocarcinoma of the Small Bowel or Ampulla of Vater NCT01202409 | M.D. Anderson Cancer Center | Phase 2 |
| Completed | A Volume, Motion, and Anatomically Adaptive Approach to Photon and Proton Beam Radiotherapy NCT02130427 | Abramson Cancer Center at Penn Medicine | N/A |
| Terminated | Cytoreductive Surgery(CRS) Plus Hyperthermic Intraoperative Peritoneal Chemotherapy(HIPC) With Cisplatin to Tr NCT01116791 | Baki Topal | Phase 2 |
| Completed | RAD001 and AV-951 in Patients With Refractory, Metastatic Colorectal Cancer NCT01058655 | Dana-Farber Cancer Institute | Phase 1 / Phase 2 |
| Completed | Activated Allogeneic Lymphocytes for Induction Graft Versus Tumor Effect in Metastatic Solid Tumors NCT00855452 | Hadassah Medical Organization | Phase 2 |
| Completed | Home Enteral Nutrition in Malnourished Patients With Gastrointestinal Cancer NCT02664974 | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | Phase 3 |
| Completed | A Phase 2, Randomized, Double Blind, Placebo Controlled Study of AMG 386 in Combination With FOLFIRI in Subjec NCT00752570 | Amgen | Phase 2 |
| Completed | Panitumumab Combination Study With Rilotumumab or Ganitumab in Wild-type Kirsten Rat Sarcoma Virus Oncogene Ho NCT00788957 | NantBioScience, Inc. | Phase 1 / Phase 2 |
| Completed | Validating M.D. Anderson Symptom Inventory (MDASI-GI) in GI Cancer Patients Under Chemotherapy NCT00849979 | M.D. Anderson Cancer Center | N/A |
| Completed | Study of Tivozanib (AV-951) Plus FOLFOX6 in Subjects With Advanced Colorectal Cancer and Other Gastrointestina NCT00660153 | AVEO Pharmaceuticals, Inc. | Phase 1 |
| Completed | Phase 2 Study of AMG 386 (20060439) in Combination With Cisplatin & Capecitabine in Subjects With Metastatic G NCT00583674 | Amgen | Phase 2 |
| Unknown | Screening to Predict Weight Loss in Patients With Cancer NCT00710632 | Queen's Medical Center | N/A |
| Terminated | Infrastructure for Developing Gastrointestinal Cancer Prognostic and Predictive Markers NCT00539318 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | — |
| Completed | Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancer NCT00436410 | National Institutes of Health Clinical Center (CC) | EARLY_Phase 1 |
| Completed | Melatonin Versus Placebo and the Effect on Appetite in Advanced Cancer Patients NCT00513357 | M.D. Anderson Cancer Center | Phase 3 |
| Terminated | Study to Evaluate the Clinical Benefit Response in Cancer Patients With Advanced Disease With AMT2003 Versus P NCT00332280 | Auron Healthcare GmbH | Phase 2 / Phase 3 |
| Completed | Bevacizumab and Erlotinib Hydrochloride in Treating Patients With Metastatic or Unresectable Biliary Tumors NCT00356889 | National Cancer Institute (NCI) | Phase 2 |
| Terminated | Effects of 3 Day Preoperative Immunonutrition in Well-nourished Patients With Gastrointestinal (GI) Cancer Und NCT01023412 | Société des Produits Nestlé (SPN) | N/A |
| Completed | Capecitabine and Oxaliplatin in Adenocarcinoma of the Small Bowel and Ampulla of Vater NCT00354887 | M.D. Anderson Cancer Center | Phase 2 |
| Completed | Study of AMG 706 in Subjects With Advanced Gastrointestinal Stromal Tumors (GISTs) NCT00089960 | Amgen | Phase 2 |
| Completed | Oxaliplatin With FOLFOX4 in Patients With Normal and Abnormal Renal Function NCT00094965 | Sanofi | Phase 2 |
| Terminated | Trial of a Sustained Release Methylphenidate in the Treatment of Fatigue in Cancer Patients NCT00516269 | M.D. Anderson Cancer Center | Phase 3 |
| Completed | Mindfulness Relaxation Compared With Relaxing Music and Standard Symptom Management Education in Treating Pati NCT00086762 | M.D. Anderson Cancer Center | N/A |
| Terminated | Bortezomib in Treating Patients With Unresectable Locally Advanced or Metastatic Adenocarcinoma of the Bile Du NCT00085410 | National Cancer Institute (NCI) | Phase 2 |
| Enrolling By Invitation | Harvesting Cells for Experimental Cancer Treatments NCT00068003 | National Cancer Institute (NCI) | — |
| Completed | Irinotecan and Cisplatin for High Grade Neuroendocrine Carcinoma of the Gastrointestinal Tract NCT00353015 | M.D. Anderson Cancer Center | Phase 2 |
| Terminated | A Double-Blind, Randomized, Placebo-Controlled Study of the Efficacy and Safety of Weekly Procrit Given to Gas NCT00254436 | M.D. Anderson Cancer Center | Phase 3 |
| Completed | Long-term Cancer Risk in the Randomised Oslo Diet and Antismoking Study NCT03410641 | Oslo University Hospital | — |